Author： Castrén Eero Kontkanen Outi
Publisher： Informa Healthcare
ISSN： 1472-8222
Source： Expert Opinion on Therapeutic Targets, Vol.6, Iss.3, 2002-06, pp. : 363-374
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Functional genomics approaches to understanding brain disorders
By Shilling Paul D Kelsoe John R
Pharmacogenomics, Vol. 3, Iss. 1, 2002-01 ,pp. :
Access to resources
Recommend
Neuropharmacology of Vestibular System Disorders
Current Neuropharmacology, Vol. 8, Iss. 1, 2010-03 ,pp. :
Tachykinins and Neuropsychiatric Disorders
Current Drug Targets, Vol. 7, Iss. 8, 2006-08 ,pp. :
The Role of Oxytocin in Neuropsychiatric Disorders
Current Medicinal Chemistry, Vol. 15, Iss. 7, 2008-03 ,pp. :
Mitochondrial Alterations and Neuropsychiatric Disorders
Current Medicinal Chemistry, Vol. 18, Iss. 30, 2011-10 ,pp. :